Business Development for the Biotech Community

line

Tukan Partners Ltd was established in 2005 as a business development consultancy, primarily for the biotech community.

The company has clients across Europe, the US and Asia and offers commercial, hands-on, transactional expertise to companies looking to add significant business development capabilities, on a part-time basis, to their growing organisations.

Tukan Partners has a successful track record in dealing with small-molecule, biologicals, generics medication and medical device companies, as well as university spin-outs, angel investments and venture-capital backed enterprises.

Typically, clients are seeking support to secure services, R&D collaborations, licensing and M&A arrangements.

line

LATEST NEWS: Abcodia and BIOUNIVERSA announce collaboration in pancreatic cancer………………Abcodia and VolitionRx collaboration advances biomarkers for cancer …………… ISA signs licensing agreement with Transgene …………… Procarta Biosystems raises equity financing …………… Heptares announces $200M agreement with Novartis Option Fund